640 related articles for article (PubMed ID: 31097977)
1. Potential Applications of NRF2 Inhibitors in Cancer Therapy.
Panieri E; Saso L
Oxid Med Cell Longev; 2019; 2019():8592348. PubMed ID: 31097977
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Nrf2 in tumor progression and its inhibitors in cancer therapy].
Tian ZY; Yang Y
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):24-32. PubMed ID: 33645047
[TBL] [Abstract][Full Text] [Related]
3. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review.
Sova M; Saso L
Drug Des Devel Ther; 2018; 12():3181-3197. PubMed ID: 30288023
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
5. The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?
Copple IM
Adv Pharmacol; 2012; 63():43-79. PubMed ID: 22776639
[TBL] [Abstract][Full Text] [Related]
6. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
7. Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy.
Lin H; Qiao Y; Yang H; Nan Q; Qu W; Feng F; Liu W; Chen Y; Sun H
Future Med Chem; 2020 Feb; 12(3):243-267. PubMed ID: 31950858
[TBL] [Abstract][Full Text] [Related]
8. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.
Namani A; Li Y; Wang XJ; Tang X
Biochim Biophys Acta; 2014 Sep; 1843(9):1875-85. PubMed ID: 24851839
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs.
Telkoparan-Akillilar P; Suzen S; Saso L
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022969
[TBL] [Abstract][Full Text] [Related]
10. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
11. Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges.
Torrente L; DeNicola GM
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():279-300. PubMed ID: 34499527
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway.
Zhou Y; Jiang Z; Lu H; Xu Z; Tong R; Shi J; Jia G
Chem Biodivers; 2019 Nov; 16(11):e1900400. PubMed ID: 31482617
[TBL] [Abstract][Full Text] [Related]
13. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
14. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Choi EJ; Jung BJ; Lee SH; Yoo HS; Shin EA; Ko HJ; Chang S; Kim SY; Jeon SM
Oncogene; 2017 Sep; 36(37):5285-5295. PubMed ID: 28504720
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
16. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
17. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Robledinos-Antón N; Fernández-Ginés R; Manda G; Cuadrado A
Oxid Med Cell Longev; 2019; 2019():9372182. PubMed ID: 31396308
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 in cancers: A double-edged sword.
Wu S; Lu H; Bai Y
Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
Bai X; Chen Y; Hou X; Huang M; Jin J
Drug Metab Rev; 2016 Nov; 48(4):541-567. PubMed ID: 27320238
[TBL] [Abstract][Full Text] [Related]
20. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
